Hao-Shen Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hao-Shen Cheng has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Achraf Shamseddine
3 shared publicationsAlan L. Ho
3 shared publications- Chien-Chih Chen
Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung 40705, Taiwan
3 shared publications Daphna Y. Gelblum
3 shared publicationsJennifer Ma
3 shared publicationsNadeem Riaz
3 shared publications
Latest Publications
- 22 October 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 249
Radiation-induced brain necrosis among patients with nasopharyngeal cancer treated with proton vs photon radiotherapy
- 22 October 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 249
Radiation-induced brain necrosis among patients with nasopharyngeal cancer treated with proton vs photon radiotherapy
- 7 September 2026
- Published by Wiley in International Journal of Cancer
Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
This retrospective study compared the efficacy and toxicity of concurrent triweekly versus weekly cisplatin in patients with previously untreated, biopsy‐proven NPC who received definitive CRT followed by adjuvant chemotherapy. Patients with distant metastasis, Karnofsky Performance Status < 80, induction chemotherapy, or no adjuvant therapy were excluded. Medical records of 205 patients treated between June 2000 and June 2023 were reviewed. Patients received triweekly cisplatin (100 mg/m 2 every 3 weeks [administered as 50 mg/m 2 on days 1 and 2 every 21 days]) or weekly cisplatin (40 mg/m 2 ), with radiotherapy to 70 Gy/35 fractions or 69.96 Gy/33 fractions. Treatment outcomes were analyzed using the Kaplan–Meier method and Cox proportional hazards model, while toxicity profiles were compared using the chi‐square test. After a median follow‐up of 76 months, the 10‐year overall survival rate was 76.5%. The cumulative cisplatin dose was higher in the triweekly group (263.9 ± 50.1 vs. 247.8 ± 35.4 mg/m 2 , p = 0.0107), while the weekly group included more patients older than 50 years (63.2% vs. 46.6%, p = 0.0338). No significant differences were observed between the triweekly and weekly groups in overall survival ( p = 0.9096) and progression‐free survival ( p = 0.9186). The weekly cisplatin group exhibited a higher incidence of Grade 1–2 hypomagnesemia ( p = 0.0415). Other acute toxicities, including gastrointestinal, renal, hematologic, otologic, neurologic, and electrolyte toxicities, as well as 1‐year post‐treatment kidney injury, hearing impairment, tinnitus, and peripheral neuropathy, were comparable between groups. These findings demonstrate similar survival outcomes and toxicity profiles between concurrent triweekly and weekly cisplatin regimens in NPC treated with curative CRT followed by adjuvant chemotherapy.
- 7 September 2026
- Published by Wiley in International Journal of Cancer
Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
This retrospective study compared the efficacy and toxicity of concurrent triweekly versus weekly cisplatin in patients with previously untreated, biopsy‐proven NPC who received definitive CRT followed by adjuvant chemotherapy. Patients with distant metastasis, Karnofsky Performance Status < 80, induction chemotherapy, or no adjuvant therapy were excluded. Medical records of 205 patients treated between June 2000 and June 2023 were reviewed. Patients received triweekly cisplatin (100 mg/m 2 every 3 weeks [administered as 50 mg/m 2 on days 1 and 2 every 21 days]) or weekly cisplatin (40 mg/m 2 ), with radiotherapy to 70 Gy/35 fractions or 69.96 Gy/33 fractions. Treatment outcomes were analyzed using the Kaplan–Meier method and Cox proportional hazards model, while toxicity profiles were compared using the chi‐square test. After a median follow‐up of 76 months, the 10‐year overall survival rate was 76.5%. The cumulative cisplatin dose was higher in the triweekly group (263.9 ± 50.1 vs. 247.8 ± 35.4 mg/m 2 , p = 0.0107), while the weekly group included more patients older than 50 years (63.2% vs. 46.6%, p = 0.0338). No significant differences were observed between the triweekly and weekly groups in overall survival ( p = 0.9096) and progression‐free survival ( p = 0.9186). The weekly cisplatin group exhibited a higher incidence of Grade 1–2 hypomagnesemia ( p = 0.0415). Other acute toxicities, including gastrointestinal, renal, hematologic, otologic, neurologic, and electrolyte toxicities, as well as 1‐year post‐treatment kidney injury, hearing impairment, tinnitus, and peripheral neuropathy, were comparable between groups. These findings demonstrate similar survival outcomes and toxicity profiles between concurrent triweekly and weekly cisplatin regimens in NPC treated with curative CRT followed by adjuvant chemotherapy.
- Open Access
- 31 August 2026
- Published by Elsevier in SSRN Electronic Journal
Radiation-Induced Brain Necrosis among patients with Nasopharyngeal Cancer Treated with Proton vs Photon Radiotherapy
Background: Radiation-induced brain necrosis (RIBN) is a late complication of radiotherapy (RT). Whether proton therapy reduces this risk relative to photon remains unclear in nasopharyngeal cancer (NPC).Methods: We retrospectively reviewed consecutive adults with NPC who received definitive chemoradiotherapy with photon intensity-modulated radiotherapy (IMRT) or proton RT between June 2013 and March 2025 and ≥6 months of follow-up. Cumulative incidence of brain necrosis (BN) was estimated treating death without BN as a competing event (Gray test); cause-specific Cox regression identified associated factors; overall survival (OS) was compared by log-rank test.Results: Of 256 patients, 79 (30.9%) received proton and 177 (69.1%) IMRT; median follow-up was 43 and 87 months, respectively. BN developed in 5/79 (6.3%) proton and 9/177 (5.1%) photon (P = .7674). The 2- and 5-year cumulative incidence of any-grade RIBN was 6.2% and 9.7% for proton versus 1.8% and 5.2% for photon (Gray P = .2342); for grade ≥2 RIBN, 4.7% and 4.7% versus 1.2% and 2.5% (Gray P = .3132). After adjustment for RT modality, age, and T stage, T4 disease remained independently associated with RIBN (adjusted HR, 7.39; 95% CI, 1.57–34.72; P = .0113), whereas proton therapy was not (adjusted HR, 1.77; 95% CI, 0.56–5.59; P = .3292). OS did not differ (5-year, 90.0% proton vs 80.7% photon; log-rank P = .1573).Conclusions: Proton therapy was not associated with a lower risk of RIBN than photon in NPC. Advanced T stage was the primary predictor, whereas survival and toxicity outcomes were similar between modalities.
- 31 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRadiation-Induced Brain Necrosis among patients with Nasopharyngeal Cancer Treated with Proton vs Photon Radiotherapy
Background: Radiation-induced brain necrosis (RIBN) is a late complication of radiotherapy (RT). Whether proton therapy reduces this risk relative to photon remains unclear in nasopharyngeal cancer (NPC).Methods: We retrospectively reviewed consecutive adults with NPC who received definitive chemoradiotherapy with photon intensity-modulated radiotherapy (IMRT) or proton RT between June 2013 and March 2025 and ≥6 months of follow-up. Cumulative incidence of brain necrosis (BN) was estimated treating death without BN as a competing event (Gray test); cause-specific Cox regression identified associated factors; overall survival (OS) was compared by log-rank test.Results: Of 256 patients, 79 (30.9%) received proton and 177 (69.1%) IMRT; median follow-up was 43 and 87 months, respectively. BN developed in 5/79 (6.3%) proton and 9/177 (5.1%) photon (P = .7674). The 2- and 5-year cumulative incidence of any-grade RIBN was 6.2% and 9.7% for proton versus 1.8% and 5.2% for photon (Gray P = .2342); for grade ≥2 RIBN, 4.7% and 4.7% versus 1.2% and 2.5% (Gray P = .3132). After adjustment for RT modality, age, and T stage, T4 disease remained independently associated with RIBN (adjusted HR, 7.39; 95% CI, 1.57–34.72; P = .0113), whereas proton therapy was not (adjusted HR, 1.77; 95% CI, 0.56–5.59; P = .3292). OS did not differ (5-year, 90.0% proton vs 80.7% photon; log-rank P = .1573).Conclusions: Proton therapy was not associated with a lower risk of RIBN than photon in NPC. Advanced T stage was the primary predictor, whereas survival and toxicity outcomes were similar between modalities.
- Open Access
- 30 April 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (04) , 513-517
A retrospective analysis of the effects of COVID-19 on cancer diagnosis and staging in Taiwan
Introduction: This study aimed to evaluate the psychological and behavioral impacts of the coronavirus disease-2019 (COVID-19) pandemic on cancer diagnosis and staging, with particular focus on patient delays and changes in healthcare-seeking behavior before and after the onset of COVID-19. Methodology: Data pertaining to 8 cancer types, including breast cancer, hepatocellular carcinoma, oral cancer, prostate cancer, gastric cancer, esophageal cancer, colon cancer, and lung cancer, sourced from the cancer registry database of Taichung Veterans General Hospital, was analyzed. The focus was on the comparisons of data between the pre-pandemic period (2017–2019) and the pandemic year (2020). Results: Breast cancer (p < 0.001), hepatocellular carcinoma (p = 0.004), prostate cancer (p < 0.001), gastric cancer (p = 0.037), and esophageal cancer (p < 0.001) exhibited a decrease in the rate of early stage patients and an increase in the rate of advanced stage patients after the COVID-19 outbreak. Furthermore, the number of newly diagnosed patients per year decreased for hepatocellular carcinoma, oral cancer, prostate cancer, gastric cancer, esophageal cancer, colon cancer, and lung cancer. Conclusions: The COVID-19 pandemic disrupted cancer care, resulting in delayed diagnoses, stage migration, and a decline in newly diagnosed cases. These findings highlight the need for resilient healthcare systems to ensure continuity of cancer screening and treatment during global health crises.
- 30 April 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (04) , 513-517
Open AccessA retrospective analysis of the effects of COVID-19 on cancer diagnosis and staging in Taiwan
Introduction: This study aimed to evaluate the psychological and behavioral impacts of the coronavirus disease-2019 (COVID-19) pandemic on cancer diagnosis and staging, with particular focus on patient delays and changes in healthcare-seeking behavior before and after the onset of COVID-19. Methodology: Data pertaining to 8 cancer types, including breast cancer, hepatocellular carcinoma, oral cancer, prostate cancer, gastric cancer, esophageal cancer, colon cancer, and lung cancer, sourced from the cancer registry database of Taichung Veterans General Hospital, was analyzed. The focus was on the comparisons of data between the pre-pandemic period (2017–2019) and the pandemic year (2020). Results: Breast cancer (p < 0.001), hepatocellular carcinoma (p = 0.004), prostate cancer (p < 0.001), gastric cancer (p = 0.037), and esophageal cancer (p < 0.001) exhibited a decrease in the rate of early stage patients and an increase in the rate of advanced stage patients after the COVID-19 outbreak. Furthermore, the number of newly diagnosed patients per year decreased for hepatocellular carcinoma, oral cancer, prostate cancer, gastric cancer, esophageal cancer, colon cancer, and lung cancer. Conclusions: The COVID-19 pandemic disrupted cancer care, resulting in delayed diagnoses, stage migration, and a decline in newly diagnosed cases. These findings highlight the need for resilient healthcare systems to ensure continuity of cancer screening and treatment during global health crises.
- Open Access
- 23 June 2025
- Published by Elsevier in Oral Oncology
- Vol. 167, 107456
Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact
- 23 June 2025
- Published by Elsevier in Oral Oncology
- Vol. 167, 107456
Open AccessMassive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact
- Open Access
- 23 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13, e51002
Enhancing the Efficiency of a Radiation Oncology Department Using Electronic Medical Records: Protocol for Preparing Radiotherapy
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Electronic medical records streamline medical processes, improve quality control, and facilitate data sharing among hospital departments. They also reduce maintenance costs and storage space needed for paper records, while saving time and providing structured data for future research. Objective: To integrate whether the radiation oncology information system and Hospital Information System (HIS) improve the electronic medical records and enhance the efficiency of the department of radiation oncology. Methods: Multidisciplinary discussions between physicians, physicists, medical radiation technologists, nurses, and engineers were held. We integrated paper records from the radiation oncology department into the existing HIS within the hospital. The new electronic interface was designed for physicians to fill in information related to radiotherapy, and detailed information about radiotherapy was also retrieved from the HIS. Finally, a new and improved electronic medical record system was launched in the HIS. Results: Since the system was launched in August 2020, more than 1,000 medical records have been entered into the system, and this figure continues to increase. The electronic medical record simplifies the radiotherapy preparation procedure, and the total time needed for the radiation preparation process has been reduced from 286.8 mins to 154.3 mins, a reduction of 46.2%. Conclusions: The integration of the radiation oncology information system and HIS has significantly increased the efficiency of radiotherapy preparation, reduced the demand for manpower and storage space, and improved electronic medical records.
- 23 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13, e51002
Open AccessEnhancing the Efficiency of a Radiation Oncology Department Using Electronic Medical Records: Protocol for Preparing Radiotherapy
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Electronic medical records streamline medical processes, improve quality control, and facilitate data sharing among hospital departments. They also reduce maintenance costs and storage space needed for paper records, while saving time and providing structured data for future research. Objective: To integrate whether the radiation oncology information system and Hospital Information System (HIS) improve the electronic medical records and enhance the efficiency of the department of radiation oncology. Methods: Multidisciplinary discussions between physicians, physicists, medical radiation technologists, nurses, and engineers were held. We integrated paper records from the radiation oncology department into the existing HIS within the hospital. The new electronic interface was designed for physicians to fill in information related to radiotherapy, and detailed information about radiotherapy was also retrieved from the HIS. Finally, a new and improved electronic medical record system was launched in the HIS. Results: Since the system was launched in August 2020, more than 1,000 medical records have been entered into the system, and this figure continues to increase. The electronic medical record simplifies the radiotherapy preparation procedure, and the total time needed for the radiation preparation process has been reduced from 286.8 mins to 154.3 mins, a reduction of 46.2%. Conclusions: The integration of the radiation oncology information system and HIS has significantly increased the efficiency of radiotherapy preparation, reduced the demand for manpower and storage space, and improved electronic medical records.
- Open Access
- 18 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Enhancing the Efficiency of a Radiation Oncology Department Using Electronic Medical Records: Protocol for Preparing Radiotherapy (Preprint)
BACKGROUND Electronic medical records (EMRs) streamline medical processes, improve quality control, and facilitate data sharing among hospital departments. They also reduce maintenance costs and storage space needed for paper records, while saving time and providing structured data for future research. OBJECTIVE This study aimed to investigate whether the integration of the radiation oncology information system and the hospital information system enhances the efficiency of the department of radiation oncology. METHODS We held multidisciplinary discussions among physicians, physicists, medical radiation technologists, nurses, and engineers. We integrated paper records from the radiation oncology department into the existing hospital information system within the hospital. A new electronic interface was designed. A comparison was made between the time taken to retrieve information from either the paper records or the EMRs for radiation preparation. A total of 30 cases were randomly allocated in both the old paper-based system and the new EMR system. The time spent was calculated manually at every step during the process, and we performed an independent 1-tailed t test to evaluate the difference between the 2 systems. RESULTS Since the system was launched in August 2020, more than 1000 medical records have been entered into the system, and this figure continues to increase. The total time needed for the radiation preparation process was reduced from 286.8 minutes to 154.3 minutes (P<.001)—a reduction of 46.2%. There was no longer any need to arrange for a nurse to organize the radiotherapy paper records, saving a workload of 16 hours per month. CONCLUSIONS The implementation of the integrated EMR system has resulted in a significant reduction in the number of steps involved in radiotherapy preparation, as well as a decrease in the amount of time required for the process. The new EMR system has provided numerous benefits for the department, including a decrease in workload, a simplified workflow, and conserving more patient data within a confined space.
- 18 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEnhancing the Efficiency of a Radiation Oncology Department Using Electronic Medical Records: Protocol for Preparing Radiotherapy (Preprint)
BACKGROUND Electronic medical records (EMRs) streamline medical processes, improve quality control, and facilitate data sharing among hospital departments. They also reduce maintenance costs and storage space needed for paper records, while saving time and providing structured data for future research. OBJECTIVE This study aimed to investigate whether the integration of the radiation oncology information system and the hospital information system enhances the efficiency of the department of radiation oncology. METHODS We held multidisciplinary discussions among physicians, physicists, medical radiation technologists, nurses, and engineers. We integrated paper records from the radiation oncology department into the existing hospital information system within the hospital. A new electronic interface was designed. A comparison was made between the time taken to retrieve information from either the paper records or the EMRs for radiation preparation. A total of 30 cases were randomly allocated in both the old paper-based system and the new EMR system. The time spent was calculated manually at every step during the process, and we performed an independent 1-tailed t test to evaluate the difference between the 2 systems. RESULTS Since the system was launched in August 2020, more than 1000 medical records have been entered into the system, and this figure continues to increase. The total time needed for the radiation preparation process was reduced from 286.8 minutes to 154.3 minutes (P<.001)—a reduction of 46.2%. There was no longer any need to arrange for a nurse to organize the radiotherapy paper records, saving a workload of 16 hours per month. CONCLUSIONS The implementation of the integrated EMR system has resulted in a significant reduction in the number of steps involved in radiotherapy preparation, as well as a decrease in the amount of time required for the process. The new EMR system has provided numerous benefits for the department, including a decrease in workload, a simplified workflow, and conserving more patient data within a confined space.